Literature DB >> 10530954

Lucidenic acid O and lactone, new terpene inhibitors of eukaryotic DNA polymerases from a basidiomycete, Ganoderma lucidum.

Y Mizushina1, N Takahashi, L Hanashima, H Koshino, Y Esumi, J Uzawa, F Sugawara, K Sakaguchi.   

Abstract

Terpenoids, 1, 2 and 3, which selectively inhibit eukaryotic DNA polymerase activities, were isolated from the fruiting body of a basidiomycete, Ganoderma lucidum, and their structures were determined by spectroscopic analyses. New terpenes, lucidenic acid O (1) and lucidenic lactone (2), prevented not only the activities of calf DNA polymerase alpha and rat DNA polymerase beta, but also these of human immunodeficiency virus type 1 reverse transcriptase. Cerevisterol (3), which was reported to be a cytotoxic steroid, inhibited only the activity of DNA polymerase alpha. Although these compounds did not influence the activities of prokaryotic DNA polymerases and other DNA metabolic enzymes such as T7 RNA polymerase and deoxyribonuclease I.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10530954     DOI: 10.1016/s0968-0896(99)00121-2

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  15 in total

1.  Analysis of triterpenoids in ganoderma lucidum using liquid chromatography coupled with electrospray ionization mass spectrometry.

Authors:  Min Yang; Xiaoming Wang; Shuhong Guan; Jiameng Xia; Jianghao Sun; Hui Guo; De-An Guo
Journal:  J Am Soc Mass Spectrom       Date:  2007-03-26       Impact factor: 3.109

2.  Novel triterpenoids inhibit both DNA polymerase and DNA topoisomerase.

Authors:  Y Mizushina; A Iida; K Ohta; F Sugawara; K Sakaguchi
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

3.  Inhibitory action of emulsified sulfoquinovosyl acylglycerol on mammalian DNA polymerases.

Authors:  Yoshiyuki Mizushina; Naoki Maeda; Miho Kawasaki; Hideki Ichikawa; Chikako Murakami; Masaharu Takemura; Xianai Xu; Fumio Sugawara; Yoshinobu Fukumori; Hiromi Yoshida; Kengo Sakaguchi
Journal:  Lipids       Date:  2003-10       Impact factor: 1.880

Review 4.  Accessing biological actions of Ganoderma secondary metabolites by in silico profiling.

Authors:  Ulrike Grienke; Teresa Kaserer; Florian Pfluger; Christina E Mair; Thierry Langer; Daniela Schuster; Judith M Rollinger
Journal:  Phytochemistry       Date:  2014-11-06       Impact factor: 4.072

5.  3β,5α,6β-Trihy-droxy-androstan-17-one.

Authors:  L C R Andrade; M J B M de Almeida; J A Paixão; J F S Carvalho; M L Sá E Melo
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-04-07

Review 6.  Detection and control of Ganoderma boninense: strategies and perspectives.

Authors:  Roozbeh Hushiarian; Nor Azah Yusof; Sabo Wada Dutse
Journal:  Springerplus       Date:  2013-10-24

7.  Ganoderma Lucidum Protects Rat Brain Tissue Against Trauma-Induced Oxidative Stress.

Authors:  Hüseyin Özevren; Sevgi İrtegün; Engin Deveci; Fırat Aşır; Gülsüm Pektanç; Şenay Deveci
Journal:  Korean J Neurotrauma       Date:  2017-10-31

8.  Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo, and in hamsters and minipigs.

Authors:  A Berger; D Rein; E Kratky; I Monnard; H Hajjaj; I Meirim; C Piguet-Welsch; J Hauser; K Mace; P Niederberger
Journal:  Lipids Health Dis       Date:  2004-02-18       Impact factor: 3.876

9.  Anticancer effect of triterpenes from Ganoderma lucidum in human prostate cancer cells.

Authors:  Lijun Qu; Sumei Li; Yumin Zhuo; Jianfan Chen; Xiaoping Qin; Guoqing Guo
Journal:  Oncol Lett       Date:  2017-10-09       Impact factor: 2.967

10.  Neuroprotective effects of ganoderma lucidum polysaccharides against oxidative stress-induced neuronal apoptosis.

Authors:  Xin-Zhi Sun; Ying Liao; Wei Li; Li-Mei Guo
Journal:  Neural Regen Res       Date:  2017-06       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.